Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
Novel proteasome inhibitors
Robert Z. Orlowski
Lymphoma-Myeloma
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Novel proteasome inhibitors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Proteasome Inhibitors
100%
Proteasome Endopeptidase Complex
87%
delanzomib
43%
marizomib
39%
ixazomib
36%
Boronic Acids
34%
carfilzomib
33%
Chymotrypsin
27%
Bortezomib
25%
Multiple Myeloma
20%
Drug Resistance
19%
Pharmacokinetics
15%
Peptides
13%
Therapeutics
3%